To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. Our first job is to listen to and observe what our customers need, and meet those needs with quality products and services. While we are not currently experiencing delays due to this pandemic, we expect that we could see them as the situation evolves. Thank you for your understanding, patience and flexibility as ATCC does everything it can to help reduce the impact of the coronavirus pandemic to our valued customers.

SARS-CoV-2 Antibody – New!

Polyclonal antibody prepared against the spike glycoprotein of SARS-CoV-2 (Wuhan-Hu-1)

Available now

Reference-quality Genomes

Create your account on the ATCC Genome Portal today for unlimited access to our growing collection of high-quality genomes.

Visit the ATCC Genome Portal

AMP 2020 Virtual Meeting

It’s time to raise the standards of your molecular research. Visit our virtual booth to see how we can collaborate on your next project.

Let’s collaborate

Reproducibility Problems

Problems with reproducibility undermine the advancement of science. Discover steps you can take to bolster scientific research.

Discover now

Organoid Models

Read the recent article featuring Dr. Clinton to discover how patient-derived 3D organoid models can support drug efficacy and toxicity screening.

Read now

Virus Culture Fundamentals

Watch the on-demand webinar for an in-depth look at the various methods used to culture and authenticate viruses.

Watch now

Solutions

Events

Webinars

Therapeutic Development

Human mesenchymal stem cells provide a promising technology for the treatment of acute respiratory distress syndrome, pneumonia, and acute lung injury. Incorporate these cells into your research today!

Vaccine Development

Using CRISPR/Cas9 gene-editing technology, we developed STAT1 knockout cell lines capable of producing high-titer viral stocks. Explore the use of these models in your vaccine research.

Molecular-based Assays

Explore a growing collection of BSL-1 and BSL-2 COVID-19 controls, including a heat-inactivated strain and genomic RNA prepared from the 2019-nCoV/USA-WA1/2020 strain and synthetic SARS-CoV-2 RNA.

FDA/EUA Assay Development

Determine the analytical specificity of your assays by performing cross-reactivity testing with viral, fungal, and bacterial species listed in the FDA EUA. Explore our extensive portfolio.

Primary cells

Choose from our extensive catalog of primary cells from normal and diseased lung tissue. Our collection includes airway epithelial cells, smooth muscle cells, and fibroblasts as well as supporting media and growth kits.

Immune cells

Study the interactions between SARS-CoV-2 and the immune system with human PBMCs, luciferase-labeled monocytes, NK cells, helper T cells, B cells, and cytotoxic T cells from ATCC!

ATCC employee opening a biorepository tank

Biorepository Services^SM

We’ll take care of the logistics and resources needed to keep your COVID-19 materials safe, so you can focus on what’s important—your research.

Custom Controls & Derivatives

We can design and produce external controls and derivatives in a variety of formats to help you verify, validate, and/or routinely monitor the performance of your workflow and assay.

ABRF-MGRG Metagenomics Reference Standards

Mock microbial communities developed and packaged as part of the Extreme Microbiome Project (XMP), comprised of long-fragment gDNA from Class I microbial genomes, and confirmed to be free of human DNA

Microbiome Reference Standards

ATCC^® Microbiome Standards are the only reference materials on the market completely manufactured from high-quality ATCC Genuine Cultures^® that are characterized by polyphasic testing, fully sequenced, and published in various databases.

Exosomes

ATCC offers exosomes derived from well-authenticated cell lines and hTERT-immortalized mesenchymal stem cells. These extracellular vesicles can be used as standards for diagnostics development, disease marker studies, and vaccine development.